Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL4902386 | 0.97 | NUDT1 (0.30) | NUDT1 | |
| Guanidine SCHEMBL1317562 | 0.89 | NUDT1 (0.30) | NUDT1 | |
| SCHEMBL29448377 | 0.86 | — | — | |
| SCHEMBL728114 | 0.84 | NUDT1 (0.47) | NUDT1 | |
| SCHEMBL5852179 | 0.80 | — | — | |
| SCHEMBL8679205 | 0.79 | — | — | |
| SCHEMBL9512818 | 0.75 | — | — | |
| SCHEMBL9714167 | 0.72 | — | — | |
| SCHEMBL31019791 | 0.72 | — | — | |
| SCHEMBL1236843 | 0.72 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814393-B2 | Substituted guanidine compounds | UBE CORPORATION (JP) | 2023-11-14 | — | — | US | disclosed |
| US-20220315599-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | UBE CORP (JP) | 2022-10-06 | — | — | US | disclosed |
| US-11396514-B2 | Substituted guanidine compounds | UBE CORPORATION | 2022-07-26 | — | — | US | disclosed |
| EP-3564230-B1 | SUBSTITUTED GUANIDINE COMPOUND | UBE INDUSTRIES (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-10759781-B2 | Substituted guanidine derivatives | UBE INDUSTRIES, LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20190337962-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | UBE INDUSTRIES, LTD. (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564230-A1 | SUBSTITUTED GUANIDINE COMPOUND | UBE Industries, Ltd. (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20190152953-A1 | SUBSTITUTED GUANIDINE DERIVATIVES | UBE INDUSTRIES, LTD. (JP) | 2019-05-23 | — | — | US | disclosed |
| EP-1837373-B1 | RESIN COMPOSITION AND FILM MADE OF SAME | KURARAY CO (JP) | 2019-03-13 | — | — | EP | disclosed |
| EP-3333163-A1 | SUBSTITUTED GUANIDINE DERIVATIVE | UBE Industries, Ltd. (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-1369438-A1 | BLOCK COPOLYMER AND THERMOPLASTIC RESIN COMPOSITION | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2003-12-10 | — | — | EP | disclosed |
| WO-2003002664-A1 | FLAME-RESISTANT POLYESTER MOULDING MATERIALS WITH POLYOLEFIN ADDITIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002643-A1 | FLAME-PROOFED POLYESTER MOULDING MATERIALS WITH ZNS | BAYER AKTIENGESELLSCHAFT (DE) | 2003-01-09 | — | — | WO | disclosed |
| US-20020176955-A1 | Fuel container having excellent gasoline barrier properties | EVAL COMPANY OF AMERICA | 2002-11-28 | — | — | US | disclosed |
| US-20020172788-A1 | Method of producing a shaped article having excellent barrier properties | KURARAY CO., LTD. (JP) | 2002-11-21 | — | — | US | disclosed |
| EP-1245381-A1 | Fuel container having excellent gasoline barrier properties | Kuraray Co., Ltd. (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1230207-A2 | METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS | Pederson, Richard L. (US) | 2002-08-14 | — | — | EP | disclosed |
| US-20020022741-A1 | Metathesis syntheses of pheromones or their components | MATERIA, INC. | 2002-02-21 | — | — | US | disclosed |
| EP-1166892-A2 | A method of producing a shaped article having excellent barrier properties | Kuraray Co., Ltd. (JP) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001036368-A2 | METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS | PEDERSON RICHARD L (US) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759781-B2 | Substituted guanidine derivatives | GMPS, GUCY1A1, GUCY1A2 | NUDT1 195/4885 |
| US-20220315599-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | GMPS, PDE3B, GUCY1A2 | NUDT1 145/4885 |
| US-11814393-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | NUDT1 145/4885 |
| US-20190152953-A1 | SUBSTITUTED GUANIDINE DERIVATIVES | GMPS, GUCY1A1, GUCY1A2 | NUDT1 195/4885 |
| US-11396514-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | NUDT1 145/4885 |
| US-20190337962-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | GMPS, PDE3B, GUCY1A2 | NUDT1 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.